December 21, 2021 | Portfolio News

Apella Announces $21 Million Series A Funding to Digitize the Operating Room

20

Novel FDA PMA & de novo 510k approvals

55

U.S. Commercial Product Launches

39

Level I Clinical Trials

29

Strategic Financings

30

Exits by IPO or M&A